Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.32−0.01 (-0.10%)
Close on Nov 18, 2026Market cap $181.59MP/E 10.2Yield –
Natures Sunshine Products pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Natures Sunshine Products's pe ratio was 10.2× on Nov 11, 2026, against 25.4× a year earlier. Over the last 5 years it ranged from 9.8× to 82.1×, with a median of 19.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.2× | −16.4 |
| 2025 | Dec 31, 2025 | 26.6× | +10.0 |
| 2024 | Dec 31, 2024 | 16.7× | −25.5 |
| 2023 | Dec 29, 2023 | 42.2× | +26.8 |
| 2022 | Dec 30, 2022 | 15.4× | −2.2 |
| 2021 | Dec 31, 2021 | 17.6× | −0.4 |
| 2020 | Dec 31, 2020 | 18.0× | −41.5 |
| 2019 | Dec 31, 2019 | 59.5× | −45.9 |
| 2017 | Jul 31, 2017 | 105.4× | +82.7 |
| 2016 | Dec 30, 2016 | 22.7× | −4.6 |
| 2015 | Dec 31, 2015 | 27.4× | +11.8 |
| 2014 | Dec 31, 2014 | 15.6× | +3.6 |
| 2013 | Dec 31, 2013 | 12.0× | +4.0 |
| 2012 | Dec 31, 2012 | 8.0× | −17.4 |
| 2011 | Dec 30, 2011 | 25.4× | +2.4 |
| 2010 | Dec 31, 2010 | 23.0× | – |
See a number that looks wrong?